Intravesical gemcitabine versus mitomycin for non-muscle invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trial

BACKGROUND: Mitomycin (MMC) has been frequently used as the compound for intravesical treatment. The relatively new pyrimidine analog gemcitabine (GEM) has exhibited anticancer effect on various solid cancers, such as the advanced bladder cancer. In this study, the GEM and MMC in treating non-muscle...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Rongxin, Li, Ye, Song, Jun, Gao, Ke, Chen, Kangning, Yang, Xiaogang, Ding, Yongqiang, Ma, Xinlong, Wang, Yang, Li, Weipeng, Wang, Yanan, Wang, Zhiping, Dong, Zhilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358190/
https://www.ncbi.nlm.nih.gov/pubmed/32660456
http://dx.doi.org/10.1186/s12894-020-00610-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358190/
https://www.ncbi.nlm.nih.gov/pubmed/32660456
http://dx.doi.org/10.1186/s12894-020-00610-9

Ejemplares similares